Publication Year

Gillespie BW, Chen Q, Reichert H, Franzblau A, Hedgeman E, Lepkowski J, Adriaens P, Demond A, et al. 2010. Estimating population distributions when some data are below a limit of detection by using a reverse Kaplan-Meier estimator. Epidemiology 21 (Suppl 4):S64-S70; doi: 10.1097/EDE.0b013e3181ce9f08. PMID: 20386104.

Naven RT, Louise-May S, Greene N. 2010. The computational prediction of genotoxicity. Exp Opin Drug Metabol Toxicol 6(7):1-11; doi: 10.1517/17425255.2010.495118. PMID: 20528613.

Gaffney SH, Burns AM, Kreider ML, Unice KM, Widner TE, Paustenbach DJ, Booher LE, Gelatt RN, Panko JM. 2010. Occupational exposure to benzene at the ExxonMobil refinery in Beaumont, TX (1976-2007). Int J Hyg Environ Health 213(4):285–301; doi: 10.1016/j.ijheh.2010.04.004.

Rish W. 2010. Practical aspects of risk assessment for Brownfield development. Chapter 25 in Davis T (ed.), Brownfields, Third Edition. American Bar Association.

Olchanski N, Slawsky KA, Plent S, Kado C, Cyr PL. 2010. Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a U.S. hospital. Hosp Prac 38(4):138-146; doi: 10.3810/hp.2010.11.351.

Reddick H. Community outreach and education program annual update. National Institute of Environmental Health Sciences (NIEHS) Center Director Meeting, Louisville, KY, 2010.

Goodsaid FM, Amur S, Aubrecht J, Burczynski ME, Catalano J, Carl K, Charlab C,…Robison TW, et al. 2010. Experience and impact of the US FDA and EMEA Voluntary Data Submissions (VXDS). Nat Rev Drug Discover 9:435-45; doi: 10.1038/nrd3116.

Shepard TH, Barr M Jr, Brent RL, Hendrickx A, Kochhar D, Oakley G, Scott WJ Jr, Rogers JM. 2010. An updated history of the Teratology Society. Birth Defects Res A 88(5):263–285; doi: 10.1002/bdra.20669.

Tachovsky JA, Haws L. Application of principal components analysis and sequential gaussian simulation to a comprehensive soil sampling dataset to predict PCDD/F concentrations in Midland, MI. Presented at Dioxin 2010, San Antonio, TX, September 2010.

Tachovsky JA, Urban JD, Wikoff DS, Haws LC, Harris MA. 2010. Reduction of a large fish tissue analyte database: Identifying and assessing data specific to a remediation site for risk assessment application. Chemosphere 80(5):481-488; doi: 10.1016/j.chemosphere.2010.04.072. PMID: 20553933.

Racz L, Datta T, Goel RK. 2010. Organic carbon effect on nitrifying bacteria in a mixed culture. Water Sci Technol 61(11):2951–2956; doi: 10.2166/wst.2010.061. PMID: 20489269.

Racz L, Goel RK. 2010. Fate and removal of estrogens from municipal wastewater. J Environ Monit 12(1):58–70; doi: 10.1039/b917298j.

Racz L, Datta T, Goel RK. 2010. Effect of organic carbon on ammonia oxidizing bacteria in a mixed culture. Bioresource Technol 101(16):6454–6460; doi: 10.1016/j.biortech.2010.03.058.

Covington T, Jakubowski E, McGuire J, Byers C, Evans R, Hulet S, Whalley C, Lumley L, Clarkson E, Gearhart J. A multi-species and -route, ion- and isomer-specific physiologically-based pharmacokinetic-pharmacodynamic model for VX. Poster presented at the Bioscience Review Conference, Baltimore, MD, May 2010.

Sistare FD, Dieterle F, Troth S, Holder DJ, Gerhold D, …, Collins N, et al. 2010. Towards consensus practices to qualify safety biomarkers for use in early drug development. Nat Biotechnol 28(5):446–454; doi: 10.1038/nbt.1634. PMID:

Dieterle F, Sistare F, Goodsaid F, Papaluca M, Ozer JS, … Collins N, et al. 2010. Renal biomarker qualification submission: A dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat Biotechnol 28(5):455–462; doi: 10.1038/nbt.1625. PMID: 20458315.

Rowlands CJ, Staskal DF, Gollapudi B, Budinsky R. 2010. The human AHR: Identification of single nucleotide polymorphisms from six ethnic populations. Pharmacogenet Genom 20(5):283-290; doi: 10.1097/fpc.0b013e32833605f8. PMID: 20401977.

Alexander DD, Schmitt DF, Tran NL, Barraj LM, Cushing CA. 2010. Partially hydrolyzed 100% whey protein infant formula and atopic dermatitis risk reduction: A systematic review of the literature. Nutr Rev 68(4):232–245; doi: 10.1111/j.1753-4887.2010.00281.x. PMID: 20416019.

Waters MD, Jackson MA, Lea IA. 2010. Characterizing and predicting carcinogenicity and mode-of-action using conventional and toxicogenomics methods. Mutat Res 705(3):184–200; doi: 10.1016/j.mrrev.2010.04.005.

Yu KO, Ruark CD, Hack CE, Sterner TR, Covington TR, Gearhart JM. A physiologically based pharmacokinetic model for pralidoxime in the guinea pig and human. Poster presented at the Society of Toxicology Annual Meeting, Salt Lake City, UT, March 2010.